Information
5.9.0 or higher
Related Solutions
Inato connects your NextGen Enterprise system to AI Patient Pre-Screening, so your team spends minutes — not hours — finding eligible patients for clinical trials.
Once connected, Inato securely pulls patient charts from NextGen, automatically redacts them, and uses AI to assess each record against a trial's inclusion and exclusion criteria, with 98% accuracy. Your staff review and confirm every match. The AI supports clinical judgment; it never replaces it.
Sites use Inato to cut chart review time by up to 90%, and to prove verified patient access to sponsors during feasibility — helping them win and deliver more trials.
HIPAA and ISO 27001 compliant, with automated chart redaction. Integration is live within 72 business hours of authorization. Setup requires only NextGen API Suite Manager and app authorization via the API Client Portal.
To get started, contact the Inato team at prescreening@inato.com.